Profound Medical (PROF) EPS (Basic) (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Profound Medical | 244.28 Mn | 193.99 Mn | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.63% |
| Dec 31, 2025 | 3.85% |
| Sep 30, 2025 | -50.00% |
| Jun 30, 2025 | 44.44% |
| Mar 31, 2025 | -82.41% |
| Dec 31, 2024 | 5,250.34% |
| Sep 30, 2024 | -32.58% |
| Jun 30, 2024 | -5.95% |
| Mar 31, 2024 | 98.77% |
| Dec 31, 2023 | -8,928.07% |
| Sep 30, 2023 | -22.87% |
| Jun 30, 2023 | 106,138.24% |
| Mar 31, 2023 | 100.00% |
| Dec 31, 2022 | -251,870.81% |
| Sep 30, 2022 | -10.86% |
| Jun 30, 2022 | -93.16% |
| Mar 31, 2022 | 116.30% |
| Dec 31, 2021 | -9,120.30% |
| Sep 30, 2021 | -92.23% |
| Jun 30, 2021 | -5.41% |
| Sep 30, 2020 | -25.35% |
| Jun 30, 2020 | 57.98% |
| Mar 31, 2020 | -87.49% |
| Dec 31, 2019 | 4,538.30% |
| Sep 30, 2019 | -100.00% |
| Jun 30, 2019 | 3,541,380.59% |